カイノスの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2023/04/03 | 1,045 | 1,058 | 1,045 | 1,046 | +5 | +0.5% | 3,200 |
2023/03/31 | 1,037 | 1,101 | 1,000 | 1,041 | -2 | -0.2% | 14,400 |
2023/03/30 | 1,031 | 1,045 | 1,031 | 1,043 | -11 | -1% | 2,200 |
2023/03/29 | 1,052 | 1,057 | 1,050 | 1,054 | +4 | +0.4% | 3,700 |
2023/03/28 | 1,052 | 1,052 | 1,048 | 1,050 | +1 | +0.1% | 2,500 |
2023/03/27 | 1,050 | 1,054 | 1,049 | 1,049 | -5 | -0.5% | 2,400 |
2023/03/24 | 1,055 | 1,062 | 1,054 | 1,054 | +3 | +0.3% | 3,100 |
2023/03/23 | 1,042 | 1,055 | 1,042 | 1,051 | -1 | -0.1% | 2,700 |
2023/03/22 | 1,050 | 1,058 | 1,050 | 1,052 | +4 | +0.4% | 6,100 |
2023/03/20 | 1,053 | 1,053 | 1,038 | 1,048 | -5 | -0.5% | 4,100 |
2023/03/17 | 1,045 | 1,054 | 1,045 | 1,053 | +11 | +1.1% | 2,000 |
2023/03/16 | 1,040 | 1,058 | 1,040 | 1,042 | -16 | -1.5% | 10,400 |
2023/03/15 | 1,048 | 1,060 | 1,048 | 1,058 | +11 | +1.1% | 3,800 |
2023/03/14 | 1,060 | 1,061 | 1,046 | 1,047 | -11 | -1% | 11,500 |
2023/03/13 | 1,075 | 1,075 | 1,058 | 1,058 | -22 | -2% | 5,700 |
2023/03/10 | 1,084 | 1,086 | 1,079 | 1,080 | -8 | -0.7% | 4,600 |
2023/03/09 | 1,087 | 1,093 | 1,084 | 1,088 | +9 | +0.8% | 6,600 |
2023/03/08 | 1,083 | 1,085 | 1,076 | 1,079 | -4 | -0.4% | 5,300 |
2023/03/07 | 1,085 | 1,087 | 1,081 | 1,083 | +2 | +0.2% | 1,500 |
2023/03/06 | 1,078 | 1,086 | 1,078 | 1,081 | ±0 | ±0% | 4,500 |
2023/03/03 | 1,083 | 1,085 | 1,081 | 1,081 | -1 | -0.1% | 2,700 |
2023/03/02 | 1,090 | 1,093 | 1,082 | 1,082 | -8 | -0.7% | 8,200 |
2023/03/01 | 1,097 | 1,097 | 1,088 | 1,090 | -7 | -0.6% | 6,700 |
2023/02/28 | 1,105 | 1,106 | 1,097 | 1,097 | -1 | -0.1% | 5,200 |
2023/02/27 | 1,095 | 1,105 | 1,095 | 1,098 | -2 | -0.2% | 8,200 |
2023/02/24 | 1,099 | 1,107 | 1,094 | 1,100 | +20 | +1.9% | 36,700 |
2023/02/22 | 1,090 | 1,090 | 1,080 | 1,080 | -11 | -1% | 8,200 |
2023/02/21 | 1,077 | 1,093 | 1,076 | 1,091 | +19 | +1.8% | 45,400 |
2023/02/20 | 1,066 | 1,075 | 1,063 | 1,072 | +8 | +0.8% | 9,600 |
2023/02/17 | 1,070 | 1,074 | 1,064 | 1,064 | -5 | -0.5% | 5,700 |
2023/02/16 | 1,072 | 1,072 | 1,063 | 1,069 | -3 | -0.3% | 2,700 |
2023/02/15 | 1,060 | 1,078 | 1,050 | 1,072 | +19 | +1.8% | 14,600 |
2023/02/14 | 1,060 | 1,060 | 1,050 | 1,053 | +2 | +0.2% | 1,900 |
2023/02/13 | 1,067 | 1,067 | 1,049 | 1,051 | -16 | -1.5% | 12,500 |
2023/02/10 | 1,065 | 1,073 | 1,065 | 1,067 | -7 | -0.7% | 4,300 |
2023/02/09 | 1,060 | 1,080 | 1,046 | 1,074 | +10 | +0.9% | 23,900 |
2023/02/08 | 1,070 | 1,075 | 1,064 | 1,064 | -9 | -0.8% | 10,600 |
2023/02/07 | 1,064 | 1,077 | 1,059 | 1,073 | +10 | +0.9% | 13,300 |
2023/02/06 | 1,075 | 1,082 | 1,059 | 1,063 | -10 | -0.9% | 16,800 |
2023/02/03 | 1,073 | 1,076 | 1,066 | 1,073 | +5 | +0.5% | 10,300 |
2023/02/02 | 1,065 | 1,072 | 1,062 | 1,068 | +7 | +0.7% | 8,300 |
2023/02/01 | 1,063 | 1,065 | 1,059 | 1,061 | -2 | -0.2% | 15,400 |
2023/01/31 | 1,067 | 1,073 | 1,063 | 1,063 | -10 | -0.9% | 9,700 |
2023/01/30 | 1,073 | 1,075 | 1,065 | 1,073 | ±0 | ±0% | 15,800 |
2023/01/27 | 1,086 | 1,088 | 1,073 | 1,073 | -11 | -1% | 46,000 |
2023/01/26 | 1,090 | 1,095 | 1,080 | 1,084 | -5 | -0.5% | 62,500 |
2023/01/25 | 1,152 | 1,187 | 1,075 | 1,089 | -52 | -4.6% | 269,700 |
2023/01/24 | 1,135 | 1,150 | 1,129 | 1,141 | +6 | +0.5% | 44,500 |
2023/01/23 | 1,142 | 1,143 | 1,124 | 1,135 | +1 | +0.1% | 18,800 |
2023/01/20 | 1,111 | 1,143 | 1,111 | 1,134 | +24 | +2.2% | 15,600 |
501~
550
件表示中 / 3682件
類似銘柄と比較する
現在ご覧いただいている「カイノス」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
カイノス | 114,300円 | +6.8% | -13.8% | 3.06% | 8.76倍 | 0.75倍 |
|
臨床検査薬の中堅メーカー。生化学、免疫血清学的検査用試薬に重点。共同開発の促進に注力 |
ティムス | 13,900円 | - | - | 0.00% | - | 2.01倍 |
|
東京農工大発創薬ベンチャー。黒カビ由来の急性期脳梗塞薬候補を中国CORXEL社に導出 |
ペルセウス | 38,000円 | +20.0% | - | 0.00% | - | 3.18倍 |
|
東大発バイオベンチャー。高機能抗体の取得に強み。抗体医薬品や抗体薬物複合体(ADC)開発 |
DWTI | 11,000円 | -15.1% | - | 0.00% | - | 6.80倍 |
|
三重大学発創薬ベンチャー。プロテインキナーゼ阻害剤開発技術はじめ眼病治療薬開発に集中 |
カルナバイオ | 25,200円 | +13.5% | - | 0.00% | - | 1.94倍 |
|
キナーゼタンパク質の販売や受託試験など創薬初期の支援事業が柱。キナーゼ阻害剤で創薬も |
市場注目の銘柄
チャート関連のコラム